SPDR S&P BIOTECH ETF (XBI)
NYSEARCA: XBI · Real-Time Price · USD
85.84
-0.73 (-0.84%)
At close: Jul 29, 2025, 4:00 PM
85.84
0.00 (0.00%)
After-hours: Jul 29, 2025, 4:30 PM EDT
XBI Holdings Information
XBI is an equity ETF with a total of 129 individual holdings. The top holdings are Moderna stock at 2.95%, Alnylam Pharmaceuticals at 2.63%, United Therapeutics at 2.60%, Regeneron Pharmaceuticals at 2.60%, and Neurocrine Biosciences at 2.60%.
Total Holdings
129
Top 10 Percentage
26.06%
Asset Class
Equity
ETF Category
Health
Assets
4.75B
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | MRNA | Moderna, Inc. | 2.95% |
| 2 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.63% |
| 3 | UTHR | United Therapeutics Corporation | 2.60% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 2.60% |
| 5 | NBIX | Neurocrine Biosciences, Inc. | 2.60% |
| 6 | HALO | Halozyme Therapeutics, Inc. | 2.59% |
| 7 | EXEL | Exelixis, Inc. | 2.59% |
| 8 | INSM | Insmed Incorporated | 2.51% |
| 9 | GILD | Gilead Sciences, Inc. | 2.50% |
| 10 | AMGN | Amgen Inc. | 2.49% |
| 11 | INCY | Incyte Corporation | 2.46% |
| 12 | VRTX | Vertex Pharmaceuticals Incorporated | 2.46% |
| 13 | BMRN | BioMarin Pharmaceutical Inc. | 2.46% |
| 14 | ABBV | AbbVie Inc. | 2.38% |
| 15 | BIIB | Biogen Inc. | 2.35% |
| 16 | BBIO | BridgeBio Pharma, Inc. | 2.29% |
| 17 | EXAS | Exact Sciences Corporation | 2.08% |
| 18 | NTRA | Natera, Inc. | 2.00% |
| 19 | CRSP | CRISPR Therapeutics AG | 1.83% |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.81% |
| 21 | TGTX | TG Therapeutics, Inc. | 1.70% |
| 22 | ROIV | Roivant Sciences Ltd. | 1.68% |
| 23 | CYTK | Cytokinetics, Incorporated | 1.56% |
| 24 | IONS | Ionis Pharmaceuticals, Inc. | 1.50% |
| 25 | PCVX | Vaxcyte, Inc. | 1.49% |
As of Jul 28, 2025